STOCK TITAN

Ginkgo Bioworks Insider's Trading Pattern Reveals Systematic Share Liquidation

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 Notice of Proposed Sale filed by Austin Che of Ginkgo Bioworks Holdings (NYSE: DNA) indicates planned sale of 99 Class A shares with an aggregate market value of $834.57, to be executed through Fidelity Brokerage Services around June 23, 2025.

The shares were originally acquired on October 12, 2022, through restricted stock vesting as compensation. The filing reveals extensive recent trading activity by the seller, with systematic sales of 99 shares per transaction over the past three months (March-June 2025), totaling 57 transactions.

Notable trading patterns show:

  • Share prices ranging from $5.15 to $9.51 per share
  • Consistent selling volume of 99 shares per trade
  • Recent price appreciation trend in June 2025, with transactions reaching $8-9 per share
  • Total outstanding shares: 46,344,630

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many DNA shares is Austin Che planning to sell according to the Form 144 filing from June 28, 2025?

According to the Form 144 filing, Austin Che plans to sell 99 shares of DNA Class A common stock through Fidelity Brokerage Services LLC, with an aggregate market value of $834.57.

What is the trading pattern of DNA shares sold by Austin Che in the past 3 months before June 2025?

Austin Che has consistently sold 99 shares of DNA Class A stock each trading day over the past 3 months. The sale prices have fluctuated, with recent transactions ranging from lows around $510.84 (April 7, 2025) to highs of $941.49 (June 12, 2025) per lot.

How did Austin Che originally acquire the DNA shares being sold?

The Form 144 indicates that Austin Che acquired the shares on October 12, 2022, through Restricted Stock Vesting as part of compensation from the issuer (Ginkgo Bioworks Holdings, Inc.).

What is the total number of DNA shares outstanding according to the June 2025 Form 144?

According to the Form 144 filing, the total number of DNA shares outstanding is 46,344,630 shares.

What was the highest sale price achieved for DNA shares by Austin Che during March-June 2025?

The highest sale price was achieved on June 12, 2025, when Austin Che's lot of 99 shares sold for $941.49, representing the peak trading value during the reported three-month period.
Ginkgo Bioworks Holdings Inc

NYSE:DNA

DNA Rankings

DNA Latest News

DNA Latest SEC Filings

DNA Stock Data

536.83M
58.30M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
BOSTON